Are IV Wellness Infusions Worth It? What the Evidence Says
PWritten by: Phil KimMedically reviewed by: Dr. Robert Aki, DPMLast medically reviewed: September 10, 2026
IV infusion therapy, where vitamins, fluids, and other compounds are delivered directly into the bloodstream, has grown into a popular wellness service. At Aloha Stem Cell we offer infusions as part of a supervised recovery and wellness program. This article takes an honest look at what the evidence says IV infusions can and cannot do, so you can decide with clear expectations.
4 of 50
states with comprehensive IV spa regulation
0
robust studies showing general wellness benefits for healthy people
5
clinical providers on the team
The appeal and the reality
The pitch for wellness IVs is often that they boost energy, immunity, or recovery faster than oral supplements. The reality is more measured. There is no robust clinical evidence that IV vitamins, hydration, or 'detox' infusions provide meaningful benefits for otherwise healthy people, and most of the claimed benefits are not backed by rigorous studies. For ordinary dehydration, oral rehydration is the simpler, safer, and recommended choice.
A lightly regulated industry
A study published in JAMA Internal Medicine in 2025 found that the IV hydration spa industry operates with very little regulation: only 4 of 50 states had comprehensive policies covering who can prescribe, who can administer, and how products are compounded. That means the onus is on the individual provider to maintain high standards, which is exactly why the setting and the team matter enormously.
When IV therapy can be appropriate
There are legitimate medical uses for IV therapy, including rehydration in specific circumstances, correcting certain nutrient deficiencies, and supporting recovery under medical supervision. The distinction is that these are targeted, supervised uses, not general wellness promises. If IV therapy is being considered, the responsible approach is a medical assessment first, a clear reason for the infusion, and full transparency about what it can and cannot do.
“A 2025 study in JAMA Internal Medicine found only 4 of 50 states had comprehensive policies governing IV hydration spas, and that product claims are largely unregulated.”
Safety considerations
When administered by trained professionals in a sterile, medically supervised setting, IV therapy is generally low risk, but it is not risk-free. Possible issues include infection, allergic reactions, vein irritation, electrolyte imbalances, and fluid overload, which is especially important for people with heart or kidney conditions. Because many infusion cocktails are compounded on site, the quality of the product and the staff matter more than the marketing.
Questions to ask before any infusion
What is the specific medical reason for this infusion?
Who prescribes it, who administers it, and under what protocols?
What exactly is in the cocktail, and who compounded it?
Do I have any heart, kidney, or other conditions that could make this risky?
What are the realistic expected benefits, and what is not supported?
A note from the clinic
We are happy to talk through whether IV therapy is appropriate for you, honestly and without pressure. At Aloha Stem Cell in Honolulu, every service starts with a real assessment. Call (808) 593-2525 or book a consultation to discuss your goals.
Our team is happy to listen to your story, answer your questions, and help you decide
whether a consultation makes sense. There is no pressure and no obligation.
The FDA now lists Regenecyte, a cord blood stem cell product, among approved cellular therapies. It is a real milestone for blood stem cell transplant patients, and it is not a treatment for joint pain. Here is what the approval is, what it is not, and why it matters when you read stem cell news.
In September 2026 the FDA granted Fast Track status to an experimental cell therapy for ALS, and in August researchers presented new Phase 1/2 data on a stem cell therapy for Parkinson's. Both are real advances and both remain investigational. Here is the honest read.
A stem cell-derived islet therapy restored insulin production in early trials, with 10 of 12 patients insulin-independent at one year. Here is what the 2025-2026 results show, what the FDA has and has not done, and what it means for people with diabetes.